{
  "id": "879233139e72fba8",
  "title": "Vera Therapeutics Announces U . S . FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy",
  "description": "20260107T220000Z",
  "content": "",
  "source": "portal.sina.com.hk",
  "source_url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2026/01/07/1430967/vera-therapeutics-announces-u-s-fda-granted-priority-review-to-biologics-license-application-for-atacicept-for-treatment-of-adults-with-iga-nephropathy/",
  "published_at": "20260107T220000Z",
  "fetched_at": "2026-01-08T00:23:56.998868+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Hong Kong",
  "raw_data": {
    "url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2026/01/07/1430967/vera-therapeutics-announces-u-s-fda-granted-priority-review-to-biologics-license-application-for-atacicept-for-treatment-of-adults-with-iga-nephropathy/",
    "url_mobile": "",
    "title": "Vera Therapeutics Announces U . S . FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy",
    "seendate": "20260107T220000Z",
    "socialimage": "https://ml.globenewswire.com/media/MjFmNDlhNzctZmQzNC00NzE5LTlhYWEtNjExMDhmNjg3Njc4LTEyMTkwMjItMjAyNi0wMS0wNy1lbg==/tiny/Vera-Therapeutics.png",
    "domain": "portal.sina.com.hk",
    "language": "English",
    "sourcecountry": "Hong Kong"
  }
}